Cardiovascular disease (CVD) is an important cause of morbidity and mortality in dialysis patients. Brachial-ankle pulse wave velocity (baPWV) is more efficient to handily assess arteriosclerosis than aortic PWV. The cardio-ankle vascular index (CAVI) is also a novel blood pressure-independent arterial stiffness parameter. In dialysis patients, both baPWV and CAVI are increased compared to general subjects. Several studies have demonstrated that increased baPWV is associated with carotid atherosclerosis and diastolic left ventricular dysfunction in hemodialysis (HD) patients. In addition, higher baPWV is related to all-cause and cardiovascular (CV) mortality. CAVI is similarly associated with CVD. However, baPWV is superior to CAVI as a predictor of CV outcomes in HD patients. Besides these outcomes, a close relationship exists between sarcopenia, abdominal visceral obesity and arterial stiffening. Reduction of thigh muscle mass is inversely correlated with baPWV and CAVI in males. Abdominal fatness is also associated with increased arterial stiffness in females. These observations provide further evidence of higher risk of CV events in HD patients with sarcopenic obesity. In addition, arterial stiffness is associated with cerebral small vessel disease and decreased cognitive function in the elderly. However, it is unknown whether arterial stiffness may be useful as an early indicator of cognitive decline in dialysis patients. Because dialysis patients are at risk of developing dementia, more studies are needed to elucidate the causal link between arterial stiffness and cognitive impairment.

Keywords:
Brachial-ankle pulse wave velocity, Cardio-ankle vascular index, Mortality, Sarcopenic obesity, Cognitive function, Hemodialysis
1.
Shirai K, Utino J, Saiki A, et al: Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev 2013;9:66-75.
2.
Turin TC, Kita Y, Rumana N, et al: Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study, Japan. Hypertens Res 2010;33:922-925.
3.
Nakamura M, Yamashita T, Yajima J, et al: Brachial-ankle pulse velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease. Hypertens Res 2010;33:1018-1024.
4.
Kim J, Song TJ, Song D, et al: Brachial-ankle pulse wave velocity is a strong predictor for mortality in patients with acute stroke. Hypertension 2014;64:240-246.
5.
Chen SC, Chang JM, Liu WC, et al: Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:724-732.
6.
Kitahara T, Ono K, Tsuchida A, et al: Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005;46:688-696.
7.
Morimoto S, Yurugi T, Aota Y, et al: Prognostic significance of ankle-brachial index, brachial-ankle pulse wave velocity, flow-mediated dilation, and nitroglycerin-mediated dilation in end-stage renal disease. Am J Nephrol 2009;30:55-63.
8.
Tanaka M, Ishii H, Aoyama T, et al: Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systematic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis. Atherosclerosis 2011;219:643-647.
9.
Kato A, Takita T, Furuhashi M, et al: A small reduction in the ankle-brachial index is associated with increased mortality in patients on chronic hemodialysis. Nephron Clin Pract 2010;114:c29-c37
10.
Kuwahara M, Hasumi S, Mandai S, et al: Rate of ankle-brachial index decline predicts cardiovascular mortality in hemodialysis patients. Ther Apher Dial 2014;18:9-18.
11.
Kato A, Takita T, Furuhashi M, et al: Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis. Ther Apher Dial 2012;16:232-241.
12.
Tanaka H, Munakata M, Kawano Y, et al: Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009;27:2022-2027.
13.
Tomiyama H, Koji Y, Yambe M, et al: Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 2005;69:815-822.
14.
Takashima N, Turin TC, Matusi K, et al: The relationship of brachial-ankle pulse wave velocity to future cardiovascular disease events in the general Japanese population: the Takashima study. J Hum Hypertens 2014;28:323-327.
15.
Maeda Y, Inoguchi T, Etoh E, et al: Brachial-ankle pulse wave velocity predicts all-cause mortality and cardiovascular events in patients with diabetes: the Kyushu Prevention Study of Atherosclerosis. Diabetes Care 2014;37:2383-2390.
16.
Kim J, Song TJ, Kim EH, et al: Brachial-ankle pulse wave velocity for predicting functional outcome in acute stroke. Stroke 2014;45:2305-2310.
17.
Washida N, Wakino S, Hayashi K, et al: Brachial-ankle pulse wave velocity predicts silent cerebrovascular disease in patients with end-stage renal disease. J Atheroscler Thromb 201;17:165-172.
18.
Munakata M, Sakuraba J, Tayama J, et al: Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res 2005;28:9-14.
19.
Fujiu A, Ogawa T, Matsuda N, et al: Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction on chronic hemodialysis patients. Circ J 2008;72:1768-1772.
20.
Namekata T, Suzuki K, Ishizuka N, et al: Establishing baseline criteria of cardio-ankle vascular index as anew indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord 2011;11:51.
21.
Nakamura K, Tomaru T, Yamamura S, et al: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J 2008;72:598-604.
22.
Mineoka Y, Fukui M, Tanaka M, et al: Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessel 2012;27:160-165.
23.
Otsuka K, Fukuda S, Shimada K, et al: Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens Res 2014;37:1014-1020.
24.
Takenaka T, Hoshi H, Kato N, et al: Cardio-ankle vascular index to screen cardiovascular disease in patients with end-stage renal diseases. J Atheroscler Thromb 2008;15:339-344.
25.
Ichihara A, Yamashita N, Takemitsu T, et al: Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. Am J Kidney Dis 2008;52:947-955.
26.
Izuhara M, Shioji K, Kadota S, et al: Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J 2008;72:1762-1767.
27.
Takaki A, Ogawa H, Wakayama T, et al: Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008;31:1347-1355.
28.
Ueyama K, Miyata M, Kubozono T, et al: Noninvasive indices of arterial stiffness in hemodialysis patients. Hypertens Res 2008;32:716-720.
29.
Kato A, Odamaki M, Ishida J, et al: Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients. Nephron Clin Pract 2008;109:c18-c24.
30.
Utescu MS, Couture V, Mac-Way F, et al: Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension 2013;62:154-160.
31.
Fortoer C, Mac-Way F, Desmeules S, et al: Aortic brachial stiffness mismatch and mortality in dialysis population. Hypertension 2015;65:378-384.
32.
Okabe R, Inaba M, Sakai S, et al: Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesis. Clin Sci (London) 2004;106:613-618.
33.
Kohara K, Ochi M, Tabara Y, et al: Arterial stiffness in sarcopenic visceral obesity in the elderly: J-SHIPP study. Int J Cardiol 2012;158:146-148.
34.
Ochi M, Kohara K, Tabara Y, et al: Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010;212:327-332.
35.
Abbatecola AM, Chiodini P, Gallo C, et al: Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age (Dordr) 2012;34:469-478.
36.
Aurélio RA, Sampaio C, Sampaio PYSW, et al: Arterial stiffness is associated with low skeletal muscle mass in Japanese community-dwelling older patients. Geriatr Gerontol Int 2014;14(suppl 1):109-114.
37.
Kato A, Ishida J, Endo Y, et al: Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 2011;26:1967-1976.
38.
Lee Y, Shin H, Vassy JL, et al: Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects. Atherosclerosis 2012;224:258-265.
39.
Kim TN, Park MS, Lim KI, et al: Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract 2011;93:285-291.
40.
Anoop S, Mistra A, Bhardwaj S, et al: High body fat and low muscle mass are associated with increased arterial stiffness in Asian Indians in North India. J Diabetes Complications 2015;20:38-43.
41.
Yurugi T, Morimoto S, Okamoto T, et al: Accumulation of visceral fat in maintenance hemodialysis patients. Clin Exp Nephrol 2012;16:156-163.
42.
Kato A, Takita T, Kumagai H: Relationship between arterial stiffening and skeletal muscle atrophy in hemodialysis patients: a gender comparative study. J Cachexia Sarcopenia Muscle 2014;5:247-249.
43.
Lu Q, Cheng LT, Wang T, et al: Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J Ren Nutr 2008;18:495-502.
44.
Kyriazis J, Tzanakis I, Stylianou K, et al: Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant 2011;26:2971-2977.
45.
Kojo G, Yoshida T, Ohkawa S, et al: Association of serum total testosterone concentration with skeletal muscle mass in men under hemodialysis. Int Urol Nephrol 2014;46:985-991.
46.
Kelly DM, Jones TH: Testosterone: a vascular hormone in health and disease. J Endocrinol 2013;217:R47-R71.
47.
Natoli AK, Medley TL, Ahimastos AA, et al: Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 2005;46:1129-1134.
48.
Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633-638.
49.
Kuang DW, Li CL, Kuok U, et al: Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao. BMC Nephrol 2012;13:143.
50.
Greenwood SA, Koufaki P, Mercer TH, et al: Effect of Exercise Training on Estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis 2015;65:425-434.
51.
Al Hazzouri AZ, Yaffe K: Arterial stiffness and cognitive function in the elderly. J Alzheimers Dis 2014;42:S503-S514.
52.
Hughes TM, Kuller LH, Barinas-Mitchell EJM, et al: Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology 2013;81:1711-1718.
53.
Singer J, Trollor JN, Baune BT, et al: Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev 2014;15:16-27.
54.
Choi SY, Park HE, Seo H, et al: Arterial stiffness using cardio-ankle vascular index reflects cerebral small vessel disease in healthy young and middle aged subjects. J Atheroscler Thromb 2013;20:178-185.
55.
Yamamoto N, Yamanaka G, Ishikawa M, et al: Cardio-ankle vascular index as a predictor of cognitive impairment in community-dwelling elderly people: four-year follow-up. Dement Geriatr Cogn Disord 2009;28:153-158.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.